Lithium significantly reduces tau phosphorylation and Aβ production by modulating AβPP processing in in vivo studies of AD mouse models (FTDP-17 tau and GSK-3β overexpressing mice) [64]. This evidence concerns the gene APP and Alzheimer disease.